#$mdr

The SP500 has pulled back 3.6% from its recent high; it was just a few days ago that the financial twitter stream was telling us that we were going to go straight up until year end.  Many reasons were given, no rate cut, money on the sidelines, managers underperforming that need to catch up, high short interest, seasonality etc...Now after this pullback it seems like everyone forgot all the positives that they were mentioning just a few days ago, they are still there. What we want to do now is perhaps take advantage of this natural retracement after the big move in October, to look for stocks that reacted well to their earnings report that have now pulled back because of the market.  By well I mean a stock that gapped up over 4% due to their report.  $VG, $MDR, $BLX, are some on my radar.

See How I Translate My Tweets & Blogs Into Actual 3rd Party Verified Trades

MOBI - Sky- mobi is down nearly 8% after EPS of $0.11 versus $0.35 year/year  

CERU - Received FDA Orphan Drug Designation for Treatment of Ovarian Cancer, shares up 7.5%

MDR - McDermott could rebound up to 35% as energy prices stabilize according to Barron's

AAL - American gets the Barron's nod, saying airline sector looks appealing.

AZN - Terminates participation in co-development of a drug with AMGN citing increased suicide, both stocks falling here.

CTRP - Priceline announced an additional $250M investment in company, shares up over 4%.

BBY - Best Buy beat on bottom line, missed top line, but shares holding 1/5% gain here.

C - Announced it plans to sell subprime lending unit Onemain Financial for $4.25B, shares up 1% in the pre.

DKS - Dicks beat EPS forecasts by 8 cents on stronger revenues, and even lowered guidance unable to derail a nice nearly 3% rally in the pre.

HALO - Halozyme beat EPS forecasts by 3 cents on stronger revenues, shares up 3% here.

MDR - McDermott beat EPS forecasts by 9 cents on stronger revenues & raised guidance, shares up over 28% in the pre.